Get started
Work

Phase II pilot study of pembrolizumab (PEM) and neoadjuvant radiation therapy (nRT) in high-risk soft tissue sarcomas (STS).

Year: 2026
Type: conference-abstract
DOI: 10.1200/jco.2026.44.16_suppl.11584
Authors: Lee D. Cranmer, Elizabeth Trice Loggers, Michael J. Wagner, Stephanie K. Schaub, Edward Y. Kim, Jesse Roberts, Matthew J. Thompson, Harveshp Mogal, Jeremy Sharib, Eleanor Y. Chen, Anshu Bandhlish, Ruohui Chen, Roxanne Moore, Niall Morin, David Siu, Rylee Johnson, Ralph Graeme Black, Shannon Maxwell, Cecilia Yeung, Seth M. Pollack
Institutions: City Of Hope National Medical Center, University of Washington, Fred Hutch Cancer Center, Dana-Farber Cancer Institute, University of Washington Medical Center, Northwestern University
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W7162548608
Cites:
Cited by:
Related to: